FDA Warning Letter — Revive Rx LLC

Case 709509 — FEI 3016710945

The FDA took a Warning Letter action against Revive Rx LLC on Sep 22, 2025 (Houston, TX). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.

Action Details

Facility
Revive Rx LLC
Date
Sep 22, 2025
Fiscal Year
2025
Product Type
Drugs
Center
CDER
Location
Houston, TX (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.